Cubtek Inc. logo

Cubtek Inc. (2252)

Market Closed
8 Dec, 05:30
TWSE TWSE
NT$
17. 95
-0.95
-5.03%
NT$
- Market Cap
- P/E Ratio
0% Div Yield
143,432 Volume
- Eps
NT$ 18.9
Previous Close
Day Range
17.25 18.9
Year Range
12.15 35.15
Want to track 2252 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2252 closed today lower at NT$17.95, a decrease of 5.03% from yesterday's close, completing a monthly increase of 0% or NT$17.95. Over the past 12 months, 2252 stock gained 0%.
2252 is not paying dividends to its shareholders.
The last earnings report, released on Aug 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

2252 Chart

Cubtek Inc. (2252) FAQ

What is the stock price today?

The current price is NT$17.95.

On which exchange is it traded?

Cubtek Inc. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 2252.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

Has Cubtek Inc. ever had a stock split?

No, there has never been a stock split.

Cubtek Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
- CEO
TWSE Exchange
- ISIN
China Country
440 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Shanghai MicroPort MedBot (Group) Co., Ltd. is a pioneering entity based in Shanghai, China, focused on the innovation, development, and commercialization of surgical robots. Founded in 2014, the company has emerged as a significant player within the People's Republic of China's medical technology sphere. As a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd., it is at the forefront of integrating artificial intelligence with robotic-assisted surgeries. The core activities of Shanghai MicroPort MedBot encompass the research, design, manufacture, and sale of an array of surgical robots tailored for various medical procedures, alongside the production of essential parts for these devices, system development, and broad distribution responsibilities. Additionally, the company engages in pivotal investment activities aimed at advancing its technological base and expanding its market reach.

Products and Services

  • Toumai
  • A laparoscopic surgical robot designed to support a wide range of surgeries, including urologic, gynecologic, thoracic, and general procedures. This product represents a significant advancement in minimally invasive surgeries, providing enhanced precision and control.

  • DFVision
  • DFVision stands out as a 3D electronic laparoscope, which is instrumental in performing intricate laparoscopic surgeries across abdominal, thoracic, and pelvic organs. Its 3D visualization capabilities offer surgeons a deeper and clearer perspective of the surgical site.

  • SkyWalker
  • This orthopedic surgical robot is specialized for knee arthroplasty and hip arthroplasty procedures. SkyWalker aims to improve the accuracy and outcomes of orthopedic surgeries, contributing to quicker patient recovery times and minimized surgical errors.

  • R-One
  • A vascular interventional surgical robot designed for coronary angioplasty. R-One utilizes advanced robotics to aid in the precision and effectiveness of treatments for coronary artery disease.

  • iSR'obot Mona Lisa
  • A robotic system focused on transperineal prostate biopsy. The Mona Lisa enhances the accuracy of biopsies, reducing the risk of infection and improving the detection rate of prostate cancer.

  • Spine surgical robots
  • Dedicated robots for spine surgery that improve the precision and safety of spinal procedures, enabling better outcomes for patients requiring surgical intervention on the spine.

  • Trans-Bronchial surgical robots
  • These robots specialize in trans-bronchial diagnosis and treatment, offering innovative approaches for lung-related diagnostics and therapies.

  • TAVR surgical robots
  • Designed for heart valve replacement surgery, these robots offer a minimally invasive solution for patients suffering from valvular heart disease, enhancing the precision of valve replacement procedures.

  • Thoracic and abdominal puncture surgical robot
  • A specialized robot for percutaneous lung biopsy and percutaneous liver biopsy, improving the accuracy and safety of thoracic and abdominal punctures.

Contact Information

Address: Building 1
Phone: 86 21 3895 4600